HB 968 Georgia House · 2025-2026 Regular Session

Controlled substances; mitragynine and hydroxymitragynine (7-OH) are Schedule I; provide

Summary
A BILL to be entitled an Act to amend Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled substances, so as to provide that mitragynine and hydroxymitragynine (7-OH) are Schedule I controlled substances; to repeal provisions relating to the regulation of kratom; to provide for related matters; to repeal conflicting laws; and for other purposes.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 14, 2026 Last action Mar 6, 2026
Maddy AI version diff · 1 comparison

What changed between versions

LC 52 0902/a LC 48 1816S/hs · 5 edits
MODERATE
This bill substitutes a new version of HB 968 that shifts from simply banning kratom to creating a regulated framework for kratom products. The new version adds specific controlled substance designations for certain kratom alkaloids, establishes detailed definitions for kratom-related terms, and creates requirements for electronic logging systems and pharmacist oversight.
Scope change
The bill's scope expanded from a complete repeal of kratom regulations to a comprehensive regulatory framework that maintains some oversight while allowing continued sale under specific conditions.
ENFORCEMENT

Changed from a complete ban on kratom to a regulated system requiring real-time electronic logging of sales with law enforcement access.

Added provisions for pharmacist availability and oversight in the sale of kratom products.

DEFINITION

Added detailed definitions for 'kratom', 'kratom extract', 'kratom product', 'processor', 'retailer', and 'pharmacist' to clarify regulatory responsibilities.

REQUIREMENT

Added requirements prohibiting sale of kratom as pressed tablets or compressed pills, and prohibiting multi-serving kratom products.

SCOPE

Modified controlled substance designations to specifically list certain alkaloid derivatives like 7-hydroxymitragynine and mitragynine in Schedule I.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
1
Committee
1
Mar 6, 2026
Lower · Passed
House Committee Favorably Reported By Substitute
lower
Jan 14, 2026
Introduced
House Hopper
lower
6 primary · 0 co-sponsors

Sponsors